홈 › 만성 폐쇄성 폐질환 › 캘리포니아
캘리포니아의 만성 폐쇄성 폐질환 임상 시험
만성 폐쇄성 폐질환 관련 연구 27개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.
캘리포니아의 도시
- Los Angeles연구 9개
- Newport Beach연구 8개
- San Francisco연구 5개
- Santa Monica연구 3개
- Long Beach연구 3개
- Buena Park연구 3개
- Santa Clarita연구 3개
- San Diego연구 3개
공식 연구 텍스트(영어)
Digital Inhaler Use in Obstructive Lung Disease Care
- Cedars-Sinai Medical Center, Los Angeles
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07214337A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50021, Encino
- Copd01 50016, Westminster
피험자 모집 중2상
40세 ~ 80세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07725939A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- NewportNativeMD, Inc., Newport Beach
- Institute of HealthCare Assessment d/b/a Apex Clinical Research, San Diego
피험자 모집 중2상
40세 ~ 75세 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07759245To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Leading Edge Research, LLC, Encino
- California Medical Research Associates Inc., Northridge
피험자 모집 중2상
40세 ~ 85세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07684820Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
- Zuckerberg San Francisco General (ZSFG) Hospital, San Francisco
- Maxine Hall Health Center (MHHC), San Francisco
- Southeast Health Center (SEHC), San Francisco
피험자 모집 중
40세 ~ 90세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT05572632A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 100, Los Angelas
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT07555483A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Los Angeles
- Research Site, Newport Beach
- Research Site, Norco
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Ark Clinical Research- Site Number : 8400113, Long Beach
- Inglewood Clinical- Site Number : 8400074, Los Angeles
- Alliance Clinical - West Hills- Site Number : 8400067, Los Angeles
- 외 1개
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07190222A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Los Angeles
피험자 모집 중2상
40세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07646587A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- IMAX Clinical Trials, La Palma
- NewportNativeMD, Inc., Newport Beach
- California Medical Research Associates, Northridge
- 외 1개
피험자 모집 중2/3상
35세 ~ 80세 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07363694Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of California at Davis, Sacramento
피험자 모집 중
40세 ~ 84세 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT06891755Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- IMAX Clinical Trials- Site Number : 8400109, La Palma
- Long Beach Research Institute- Site Number : 8400027, Long Beach
- Downtown L.A. Research Center- Site Number : 8400009, Los Angeles
- 외 3개
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07190209STRIVE Post-Market Registry Study
- El Camino, Taft Center for Clinical Research, Mountain View
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT04302272A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
- University of California, San Francisco, San Francisco
피험자 모집 중
22세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT07119229A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Palo Alto
- Research Site, Redding
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06878261Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, Bakersfield
- GSK Investigational Site, Modesto
- GSK Investigational Site, Newport Beach
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Castroville
- Research Site, Garden Grove
- Research Site, Inglewood
- 외 12개
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06283966Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of San Francisco, San Francisco
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Garden Grove
- Research Site, Newport Beach
- Research Site, Torrance
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06883305Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of California, Los Angeles, Los Angeles
피험자 모집 중3상
40세 이상 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Newport Beach
피험자 모집 중3상
40세 ~ 75세 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT07177339Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
- San Francisco VA Medical Center, San Francisco
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT04722835The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
- UCSD Sleep Research, La Jolla
피험자 모집 중2상
40세 ~ 79세 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05237505SPIROMICS Study of Early COPD Progression (SOURCE)
- University of California Los Angeles, Los Angeles
- University of California, San Francisco, San Francisco
피험자 모집 중관찰 연구건강한 지원자 환영
30세 ~ 55세 · 모든 성별 · 2026. 6. 3. 업데이트됨 · NCT05033990PiMZ Longitudinal Cohort (PiMZ Logic)
- University of California- Los Angeles, Los Angeles
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 1. 16. 업데이트됨 · NCT06505603Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Science 37, Los Angeles
피험자 모집 중관찰 연구
50세 이상 · 모든 성별 · 2025. 8. 5. 업데이트됨 · NCT06122077Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
- Arthur F Gelb MD, Lakewood
- Arthur F Gelb MD, Lakewood
피험자 모집 중관찰 연구건강한 지원자 환영
30세 이상 · 모든 성별 · 2023. 10. 27. 업데이트됨 · NCT03263130ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.